The US pension risk transfer market has had, to put it mildly, a sluggish first half of the year, at least in terms of annual premium. Just $4bn of buy-in and buy-out sales in Q1 were followed by only $3bn in Q2, declines of 47% and 27%, respectively.

Want to read the full article?

You can read this article and more on lminvestor.com.

Read Article

Insurers are favouring funded re as it helps firms manage the market and longevity risks associated with writing bulk purchase annuity (BPA) business by reducing capital charges and therefore making PRT deals more competitive. 

Unsurprisingly, given its growth and potential for capital optimisation, UK regulators have been carefully watching the increased use of funded re. In June 2023, the Prudential Regulatory Authority (PRA) sent a “Dear CRO’ letter to heads of risk at UK life insurers.

The letter outlined the regulator’s two main concerns from a sectoral review which it had carried out.

“One of the key risks arising in funded re is that firms recapture sub-optimal portfolios with depressed values and with limited ability to be transformed effectively to the firms’ preferred portfolio,” the PRA letter said.

Related Posts